2017 Q2 Form 10-Q Financial Statement
#000143774917014436 Filed on August 10, 2017
Income Statement
Concept | 2017 Q2 | 2016 Q2 |
---|---|---|
Revenue | ||
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $3.570M | $4.290M |
YoY Change | -16.78% | 34.48% |
% of Gross Profit | ||
Research & Development | $4.650M | $4.988M |
YoY Change | -6.78% | 80.2% |
% of Gross Profit | ||
Depreciation & Amortization | $80.00K | $30.00K |
YoY Change | 166.67% | 50.0% |
% of Gross Profit | ||
Operating Expenses | $8.224M | $9.275M |
YoY Change | -11.33% | 55.73% |
Operating Profit | -$8.224M | -$9.275M |
YoY Change | -11.33% | 55.73% |
Interest Expense | $1.443M | $1.475M |
YoY Change | -2.17% | 125.54% |
% of Operating Profit | ||
Other Income/Expense, Net | $1.703M | $19.04M |
YoY Change | -91.06% | -180.04% |
Pretax Income | -$6.521M | $9.764M |
YoY Change | -166.79% | -132.83% |
Income Tax | -$4.000K | -$4.000K |
% Of Pretax Income | -0.04% | |
Net Earnings | -$6.517M | $9.768M |
YoY Change | -166.72% | -132.84% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | -$0.44 | $0.59 |
Diluted Earnings Per Share | -$0.44 | -$0.58 |
COMMON SHARES | ||
Basic Shares Outstanding | 14.65M | 14.60M |
Diluted Shares Outstanding | 14.65M | 15.44M |
Balance Sheet
Concept | 2017 Q2 | 2016 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $53.50M | $82.60M |
YoY Change | -35.23% | 28.66% |
Cash & Equivalents | $12.39M | $27.51M |
Short-Term Investments | $41.10M | $55.10M |
Other Short-Term Assets | $1.900M | $1.900M |
YoY Change | 0.0% | 216.67% |
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | $0.00 | |
Total Short-Term Assets | $55.36M | $84.57M |
YoY Change | -34.53% | 30.45% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $2.148M | $1.105M |
YoY Change | 94.39% | 213.92% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $11.20M | $18.90M |
YoY Change | -40.74% | |
Other Assets | $321.0K | $111.0K |
YoY Change | 189.19% | 98.21% |
Total Long-Term Assets | $13.68M | $20.07M |
YoY Change | -31.81% | 1074.14% |
TOTAL ASSETS | ||
Total Short-Term Assets | $55.36M | $84.57M |
Total Long-Term Assets | $13.68M | $20.07M |
Total Assets | $69.05M | $104.6M |
YoY Change | -34.01% | 57.25% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $6.300M | $5.400M |
YoY Change | 16.67% | 10.2% |
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $200.0K | $2.000M |
YoY Change | -90.0% | |
Total Short-Term Liabilities | $6.592M | $7.391M |
YoY Change | -10.81% | 50.53% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $92.00M | $90.40M |
YoY Change | 1.77% | 378.31% |
Other Long-Term Liabilities | $1.472M | $478.0K |
YoY Change | 207.95% | -98.78% |
Total Long-Term Liabilities | $1.472M | $478.0K |
YoY Change | 207.95% | -99.18% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $6.592M | $7.391M |
Total Long-Term Liabilities | $1.472M | $478.0K |
Total Liabilities | $108.3M | $104.3M |
YoY Change | 3.86% | 65.36% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$144.2M | -$97.99M |
YoY Change | 47.14% | 14.11% |
Common Stock | $104.9M | $98.32M |
YoY Change | 6.69% | 10.05% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$39.28M | $333.0K |
YoY Change | ||
Total Liabilities & Shareholders Equity | $69.05M | $104.6M |
YoY Change | -34.01% | 57.25% |
Cashflow Statement
Concept | 2017 Q2 | 2016 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$6.517M | $9.768M |
YoY Change | -166.72% | -132.84% |
Depreciation, Depletion And Amortization | $80.00K | $30.00K |
YoY Change | 166.67% | 50.0% |
Cash From Operating Activities | -$6.470M | -$8.270M |
YoY Change | -21.77% | 57.52% |
INVESTING ACTIVITIES | ||
Capital Expenditures | -$40.00K | -$150.0K |
YoY Change | -73.33% | 650.0% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $6.080M | -$40.31M |
YoY Change | -115.08% | |
Cash From Investing Activities | $6.040M | -$40.47M |
YoY Change | -114.92% | 202250.0% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -60.00K | 20.00K |
YoY Change | -400.0% | -99.97% |
NET CHANGE | ||
Cash From Operating Activities | -6.470M | -8.270M |
Cash From Investing Activities | 6.040M | -40.47M |
Cash From Financing Activities | -60.00K | 20.00K |
Net Change In Cash | -490.0K | -48.72M |
YoY Change | -98.99% | -190.29% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$6.470M | -$8.270M |
Capital Expenditures | -$40.00K | -$150.0K |
Free Cash Flow | -$6.430M | -$8.120M |
YoY Change | -20.81% | 55.26% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2016Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
-20763000 | |
CY2017Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
8311000 | |
CY2016Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
6043000 | |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
3693000 | ||
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
-31041000 | ||
CY2017Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
11834000 | |
CY2016Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
27479000 | |
CY2016Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
4618000 | |
CY2015Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
37839000 | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-4740000 | ||
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
|||
CY2017Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3574000 | |
CY2016Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4287000 | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
6840000 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8023000 | ||
CY2017Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-6521000 | |
CY2017Q2 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
||
CY2016Q2 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
||
CY2016Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-4000 | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-8000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8000 | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-2318000 | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-693000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
101000 | ||
CY2016Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
9764000 | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-22847000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
6842000 | ||
CY2017Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-4000 | |
CY2016Q2 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
144000 | |
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
114000 | ||
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
246000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
32000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
151000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1932000 | ||
CY2016Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
838000 | |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1037000 | ||
CY2017Q2 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
13000 | |
us-gaap |
Interest Paid
InterestPaid
|
2857000 | ||
us-gaap |
Interest Paid
InterestPaid
|
182000 | ||
CY2017Q2 | us-gaap |
Liabilities
Liabilities
|
108325000 | |
CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
103583000 | |
CY2017Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
69048000 | |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
84887000 | |
CY2017Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6592000 | |
CY2017Q2 | us-gaap |
Interest Expense
InterestExpense
|
1443000 | |
CY2016Q2 | us-gaap |
Interest Expense
InterestExpense
|
1475000 | |
us-gaap |
Interest Expense
InterestExpense
|
2884000 | ||
us-gaap |
Interest Expense
InterestExpense
|
2625000 | ||
CY2016Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
51003000 | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-123000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
63632000 | ||
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6642000 | |
CY2017Q2 | us-gaap |
Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
|
8311000 | |
CY2016Q4 | us-gaap |
Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
|
4618000 | |
CY2017Q2 | us-gaap |
Long Term Investments
LongTermInvestments
|
11215000 | |
CY2016Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
8200000 | |
CY2017Q2 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
0 | |
CY2016Q4 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
0 | |
CY2017Q2 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
41107000 | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
23087000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
11741000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-55201000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-15994000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-12139000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-22839000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
6834000 | ||
CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
9768000 | |
CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6517000 | |
CY2016Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
8631000 | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
6036000 | ||
CY2016Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-9001000 | |
us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-21167000 | ||
CY2017Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1703000 | |
CY2016Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
19039000 | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-7243000 | ||
CY2016Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
9275000 | |
us-gaap |
Operating Expenses
OperatingExpenses
|
15604000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
16245000 | ||
CY2017Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8224000 | |
CY2017Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
8224000 | |
CY2017Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
321000 | |
CY2016Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9275000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-15604000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-16245000 | ||
CY2016Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
41000 | |
CY2017Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1472000 | |
CY2016Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1153000 | |
CY2016Q2 | us-gaap |
Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
|
1137000 | |
CY2016Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
360000 | |
CY2017Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
112000 | |
CY2016Q2 | us-gaap |
Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
|
18769000 | |
us-gaap |
Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
|
28001000 | ||
us-gaap |
Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
|
|||
us-gaap |
Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
|
673000 | ||
us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
50000 | ||
us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
|||
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
20922000 | ||
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
65627000 | ||
us-gaap |
Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
|
798000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
143000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
219000 | ||
CY2017Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2015Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2015Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2017Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2017Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
9250 | ||
CY2016Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
14933 | |
CY2017Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
9250 | |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
14933 | ||
CY2017Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-39277000 | |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-18696000 | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2279000 | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
13333 | ||
kmph |
Common Stock Issued During Period From Warrants Exercised
CommonStockIssuedDuringPeriodFromWarrantsExercised
|
698 | ||
kmph |
Common Stock Issued During Period From Warrants Exercised
CommonStockIssuedDuringPeriodFromWarrantsExercised
|
141095 | ||
kmph |
Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
|
60000 | ||
kmph |
Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
|
|||
CY2017Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
CY2017Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
771000 | |
CY2016Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
489000 | |
us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Reclassifications</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> the Company early adopted Accounting Standards Update (“ASU”) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Statements of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">320</div>) – Restricted Cash</div> ("ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18"</div>), which </div>addresses the treatment of restricted cash and restricted cash equivalents in the statement of cash flows<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">. The adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> reduced the Company’s net cash used in investing activities and net decrease in cash and cash equivalents on the condensed statements of cash flows by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.1</div></div> million for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2016, </div>as compared to the net cash used in investing activities and net decrease in cash and cash equivalents on the condensed statements of cash flows if the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> early adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18.</div> This reclassification had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the condensed balance sheets or statements of operations. </div></div></div></div> | ||
us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
|||
us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
82800000 | ||
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
32806000 | ||
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
10645000 | ||
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
4000 | ||
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
141000 | ||
CY2017Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2148000 | |
CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1970000 | |
us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
77000 | ||
us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
15000 | ||
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
|||
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
18621000 | ||
CY2017Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4650000 | |
CY2016Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4988000 | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8764000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8222000 | ||
CY2017Q2 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
1100000 | |
CY2016Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
1100000 | |
CY2016 | us-gaap |
Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
|
3 | |
CY2017Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-144179000 | |
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-121340000 | |
CY2017Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
||
CY2016Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
||
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
|||
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
|||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2254000 | ||
CY2016Q2 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
8631000 | |
us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
6036000 | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with GAAP<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">On an ongoing basis, the Company evaluates its estimates, including those rel<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">ated to the useful lives of property and equipment, and assumptions used for purposes of determining stock-based compensation, income taxes, and the fair value of the derivative and warrant liability, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</div></div></div></div></div> | ||
CY2016Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15435322 | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15583390 | ||
CY2017Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14649586 | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14648291 | ||
CY2016Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14597449 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14546576 | ||
CY2017Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14649586 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14648291 | ||
kmph |
Deferred Offering Costs Writeoff
DeferredOfferingCostsWriteoff
|
|||
kmph |
Deferred Offering Costs Writeoff
DeferredOfferingCostsWriteoff
|
445000 | ||
CY2017Q2 | kmph |
Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
|
8311000 | |
CY2016Q4 | kmph |
Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
|
4618000 | |
CY2017Q2 | kmph |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
|
||
CY2016Q2 | kmph |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
|
673000 | |
kmph |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
|
|||
kmph |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
|
755000 | ||
kmph |
Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
|
7000 | ||
kmph |
Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
|
50000 | ||
kmph |
Transfer Of Warrants To Equity Upon Exercise
TransferOfWarrantsToEquityUponExercise
|
755000 | ||
CY2017Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6303000 | |
CY2016Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6444000 | |
CY2017Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
||
CY2016Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5003000 | |
CY2017Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
104901000 | |
kmph |
Gain Loss On Subleases
GainLossOnSubleases
|
-102000 | ||
kmph |
Gain Loss On Subleases
GainLossOnSubleases
|
|||
kmph |
Transfer Of Warrants To Equity Upon Exercise
TransferOfWarrantsToEquityUponExercise
|
|||
CY2016Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
102643000 | |
CY2017Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1165000 | |
CY2016Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1257000 | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2254000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2279000 | ||
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
2220000 | ||
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
2443000 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
780000 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
835000 | ||
CY2017Q2 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
390000 | |
CY2016Q2 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
393000 | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
11692975 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9532398 | ||
CY2017Q2 | us-gaap |
Assets
Assets
|
69048000 | |
CY2016Q4 | us-gaap |
Assets
Assets
|
84887000 | |
CY2017Q2 | us-gaap |
Assets Current
AssetsCurrent
|
55364000 | |
CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
74357000 | |
CY2017Q2 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
52322000 | |
CY2016Q4 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
59203000 | |
CY2017Q2 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
177000 | |
CY2016Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
157000 | |
us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
284000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-3708000 | ||
CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
17862000 | |
CY2015Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
32318000 | |
CY2017Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
13486000 | |
CY2016Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
28610000 | |
CY2017Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
548000 | ||
CY2017Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
12386000 | |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
16762000 | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-4376000 | ||
CY2017Q2 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
12621775 | |
CY2016Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
12114618 | |
CY2017Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14657430 | |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14646982 | |
CY2017Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | |
CY2015Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
CY2015Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
CY2015Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
CY2017Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14657430 | |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14646982 | |
CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | |
CY2017Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
91950000 | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
55000 | ||
CY2016Q2 | us-gaap |
Dividends
Dividends
|
||
us-gaap |
Dividends
Dividends
|
|||
CY2016Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
91170000 | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
164000 | ||
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-31041000 | ||
CY2017Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-3523000 | |
CY2016Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-20763000 | |
CY2016Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.59 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.41 | ||
CY2017Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.44 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.56 | ||
CY2016Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.58 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.36 | ||
CY2017Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.44 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.56 | ||
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
3693000 | ||
CY2017Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
-3523000 |